慢性丙型肝炎患者自身抗体检测的影响因素及临床意义
摘要
关键词
全文:
PDF参考
姜宏达,周海舟.慢性丙型肝炎样本血清自身抗体检测及其临床意义研究现状[J].实用肝脏病杂志,2018,21(5):817-820.
K Zachou, PMuratori, GK Koukoulis, et al. Review article: Autoimmune hepatitis current management and challenges[J].World Journal of Gastroenterology,2014(4):483-491.
Marconcini ML, Fayad L, Shiozawa MB, et al. Autoantibody profile in individuals with chronic hepatitis C[J]. Rev Soc Bras Med Trop,2013,46:147-153.
Shao C, Huo N, Zhao L, et al. The presence of thyroid peroxidase antibody of IgG2 subclass is a risk factor for thyroid dysfunction in chronic hepatitis C patients[J]. Eur J Endocrinol, 2013(168):717-722.
Meghan E Sise, Allyson K Bloom, Jessica Wisocky, et al. Treatment of hepatitis C virusassociated mixed cryoglobulinemia with direct acting antiviral agents[J]. Hepatology, 2016(2):437-439.
Rigopoulou EI, Zachou K, Gatselis N, et al. Autoimmune hepatitis in patients with chronic HBV and HCV infections:Patterns of clinical characteristics, disease progression and outcome[J].Ann Hepatol,2013(13):127-135.
练明建,王前明,曾秀雅.肝硬化样本自身抗体检测的临床意义[J].中国老年病学杂志,2018,12(38):5710-5712.
Lian M,Hua J,Sheng L,et al.Prevalence and significance of autoanti bodies in patients with alcoholic liver disease[J]. Dig Dis, 2013,14(7):396-401.
甘志超,刘莹,赵冰红,等.丙型肝炎样本自身抗体检出率、丙肝病毒载量及肝功能间的相关性[J].现代检验医学杂志,2016,
(3):108-110+113.
DOI: http://dx.doi.org/10.12345/yzlcyxzz.v4i5.7721
Refbacks
- 当前没有refback。
此作品已接受知识共享署名-非商业性使用 4.0国际许可协议的许可。